sábado, 13 de abril de 2024

Ten Doctors on FDA Panel Reviewing Abbott Heart Device Had Financial Ties With Company By David Hilzenrath and Holly K. Hacker APRIL 8, 2024

https://kffhealthnews.org/news/article/abbott-triclip-fda-advisory-panel-payments-funding-conflict-of-interest/?utm_campaign=KHN%20-%20Weekly%20Edition&utm_medium=email&_hsenc=p2ANqtz-8-BFzb4_p7mJlrF-HVwaX0CrPHnoGC9lDepcrgkjhoKddcdLHcppefvC-wuaCE7Dc6l4ynLskbq1DZywTxMawO-w1uXg&_hsmi=302404103&utm_content=302404103&utm_source=hs_email When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database.

No hay comentarios: